Balance Sheet

Assets

+14%

+39%

10Y

Currency: KRW

	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	3 891	4 993	5 703	7 447	18 000	16 819	26 438	31 118	22 877	18 393	10 008	24 310	40 004	40 481	60 829	26 896	23 914	33 703
Cash	0	0	0	0	0	22	33	30	28	16	12	22	14	25	20	32	24	13
Cash Equivalents	3 891	4 993	5 703	7 447	18 000	16 797	26 405	31 088	22 849	18 377	9 996	24 288	39 990	40 456	60 808	26 864	23 889	33 690
Short-Term Investments	0	2 105	3 712	486	385	9 356	615	11 719	17 774	23 855	32 013	36 851	37 762	53 764	62 374	115 736	127 138	98 615
Total Receivables	25 763	29 840	35 410	46 653	46 417	36 746	38 431	41 129	45 541	45 090	51 473	51 559	46 274	40 088	36 993	40 533	43 454	49 718
Accounts Receivables	24 142	28 754	31 344	43 908	41 284	35 398	36 448	39 514	42 748	42 772	48 963	49 494	45 869	39 553	35 904	40 117	42 087	42 010
Other Receivables	1 621	1 086	4 066	2 745	5 133	1 348	1 983	1 615	2 793	2 318	2 510	2 065	405	535	1 089	416	1 367	7 707
Inventory	9 627	13 044	17 223	17 301	22 729	30 035	27 070	27 209	25 619	27 683	33 835	39 472	40 117	46 015	42 434	41 067	49 142	62 021
Other Current Assets	472	380	262	264	419	227	272	252	321	364	487	263	361	576	1 728	161	1 086	697
Total Current Assets	39 753	50 362	62 310	72 152	87 950	93 184	92 825	111 427	112 132	115 385	127 816	152 455	164 517	180 924	204 357	224 392	244 735	244 753
PP&E Net	25 086	24 769	45 060	46 521	53 645	59 686	65 494	67 003	76 602	77 255	95 823	106 538	120 173	123 631	120 804	136 445	155 279	158 402
PP&E Gross	25 086	24 769	45 060	46 521	53 645	59 686	65 494	67 003	76 602	77 255	95 823	106 538	120 173	123 631	120 804	136 445	155 279	158 402
Accumulated Depreciation	24 110	27 721	31 545	35 161	36 712	39 454	45 157	42 259	44 223	42 346	47 065	53 043	58 310	65 418	71 179	73 213	81 011	88 155
Intangible Assets	1 443	1 423	1 826	1 631	1 673	2 309	2 349	3 572	4 401	5 476	6 496	5 549	5 987	6 223	7 268	8 808	9 343	9 223
Note Receivable	2 815	5 030	3 503	2 123	1 556	6 209	6 389	5 196	4 248	417	640	0	2 180	3 108	3 183	3 112	2 056	2 378
Long-Term Investments	6 114	4 537	6 922	19 120	22 927	23 855	24 150	27 300	32 282	34 854	34 062	36 520	37 760	38 723	43 571	44 425	56 638	58 443
Other Long-Term Assets	1 818	1 802	2 880	2 992	2 335	2 335	2 332	2 602	844	833	960	894	627	823	849	709	809	729
Total Assets	77 028 N/A	87 924 +14%	122 502 +39%	144 539 +18%	170 086 +18%	187 577 +10%	193 539 +3%	217 101 +12%	230 509 +6%	234 220 +2%	265 796 +13%	301 955 +14%	331 244 +10%	353 433 +7%	380 033 +8%	417 891 +10%	468 860 +12%	473 929 +1%
Liabilities
Accounts Payable	1 974	1 728	3 077	4 000	4 965	5 274	6 693	4 995	6 775	6 099	6 829	7 168	7 389	5 879	6 359	8 354	8 096	6 498
Accrued Liabilities	5 021	6 132	8 933	10 263	9 573	8 893	9 628	10 572	11 857	13 149	15 652	15 488	15 044	15 032	17 277	18 952	19 034	20 948
Short-Term Debt	11 780	16 080	14 580	17 334	15 695	6 738	1 724	3 282	7 280	7 645	10 606	18 537	18 500	21 568	16 000	16 000	23 500	0
Current Portion of Long-Term Debt	5 421	420	733	1 420	2 519	5 803	3 783	1 708	7 200	3 000	7 572	3 350	2 278	2 913	4 020	6 067	5 007	1 824
Other Current Liabilities	2 214	2 830	4 356	4 232	5 692	7 876	4 832	7 868	5 562	9 744	9 501	15 530	15 489	14 400	17 198	16 507	16 959	18 924
Total Current Liabilities	26 410	27 190	31 678	37 249	38 443	34 584	26 659	28 425	38 674	39 637	50 160	60 073	58 700	59 791	60 855	65 880	72 595	48 195
Long-Term Debt	2 369	3 413	5 879	6 201	9 144	10 690	18 307	19 779	13 392	10 572	7 000	6 650	11 885	11 386	12 971	8 232	11 832	13 824
Deferred Income Tax	0	0	2 503	2 962	2 962	4 080	4 223	3 573	2 935	2 138	1 470	598	620	472	187	746	877	1 853
Minority Interest	0	0	0	11	11	8	7	7	0	0	0	0	0	0	0	0	0	0
Other Liabilities	4 069	4 170	3 692	4 002	6 494	4 747	2 913	3 490	3 517	4 486	5 485	6 151	4 939	4 893	5 312	5 176	4 875	3 850
Total Liabilities	32 848 N/A	34 773 +6%	43 752 +26%	50 425 +15%	57 054 +13%	54 109 -5%	52 109 -4%	55 273 +6%	58 518 +6%	56 833 -3%	64 115 +13%	73 472 +15%	76 145 +4%	76 542 +1%	79 324 +4%	80 034 +1%	90 179 +13%	67 722 -25%
Equity
Common Stock	7 513	7 513	7 513	7 513	7 742	7 742	7 742	8 104	8 104	8 104	8 104	8 104	8 116	8 122	8 122	8 122	8 122	8 167
Retained Earnings	24 987	33 125	46 442	75 062	93 807	108 558	118 913	136 528	155 072	171 196	195 359	222 098	248 128	269 848	293 301	333 084	375 463	401 373
Additional Paid In Capital	10 862	10 937	11 549	11 662	13 567	14 820	15 200	17 719	17 722	17 860	18 016	18 074	18 645	19 121	18 730	18 730	18 730	20 342
Unrealized Security Profit/Loss	1 506	2 249	13 778	2 330	2 340	2 328	2 330	2 348	2 348	2 349	2 336	2 338	2 341	1 933	1 962	1 968	1 987	2 368
Treasury Stock	734	734	586	2 536	4 515	0	2 713	2 731	11 149	22 164	22 164	22 164	22 164	22 164	22 164	25 211	27 169	27 169
Other Equity	47	62	54	82	90	21	42	141	105	43	32	32	33	31	757	1 163	1 547	1 126
Total Equity	44 180 N/A	53 151 +20%	78 749 +48%	94 114 +20%	113 032 +20%	133 469 +18%	141 430 +6%	161 828 +14%	171 991 +6%	177 387 +3%	201 682 +14%	228 482 +13%	255 099 +12%	276 891 +9%	300 709 +9%	337 856 +12%	378 681 +12%	406 207 +7%
Total Liabilities & Equity	77 028 N/A	87 924 +14%	122 502 +39%	144 539 +18%	170 086 +18%	187 577 +10%	193 539 +3%	217 101 +12%	230 509 +6%	234 220 +2%	265 796 +13%	301 955 +14%	331 244 +10%	353 433 +7%	380 033 +8%	417 891 +10%	468 860 +12%	473 929 +1%
Shares Outstanding
Common Shares Outstanding	15	15	15	15	15	16	15	16	15	15	15	15	15	15	15	15	15	15

Income Statement Balance Sheet Cash Flow Statement

Korea United Pharm Inc
KRX:033270

Balance Sheet

Balance Sheet Decomposition
Korea United Pharm Inc

Balance Sheet
Korea United Pharm Inc

See Also

Company

Help

Tools

Stocks

Korea United Pharm Inc KRX:033270

Balance Sheet

Balance Sheet Decomposition Korea United Pharm Inc

Balance Sheet Korea United Pharm Inc

See Also

Company

Help

Tools

Stocks

Korea United Pharm Inc
KRX:033270

Balance Sheet Decomposition
Korea United Pharm Inc

Balance Sheet
Korea United Pharm Inc